These are Gilead scientists. They’re not just experts in oncology, virology and inflammation: They’re relentless thinkers with an unwavering commitment to discovery. Here, in our labs, every intricate step, reset and do-over plays a critical role in helping set and achieve bold ambitions in our fight against the world’s most devastating diseases. #GileadLife | Gilead Sciences
0:28
These are Gilead scientists. They’re not just experts in oncology, virol…
93.8K views8 months ago
FacebookGilead Sciences
We’re paving the way for the future pipeline in oncology and inflammation with a new state-of-the-art Research Center that’s under construction. Take a hard hat tour with us to learn what makes the new labs so unique and how it’s part of Gilead’s bigger investment in U.S. manufacturing and R&D capabilities. gilead.inc/3UZtK1Z | Gilead Sciences
0:46
We’re paving the way for the future pipeline in oncology and inflamma…
178 views7 months ago
FacebookGilead Sciences
Scientific progress is measured in more than data points. It’s measured in the people reached, the questions answered and the impact made. From diverse clinical trials to advances in virology, oncology and inflammation, these numbers reflect the real-world progress behind our work. Because at Gilead, we innovate for impact. Read more in our 2024 Responsible Business and Impact Report: https://gilead.inc/3Eu4JHC | Gilead Sciences
0:32
Scientific progress is measured in more than data points. It’s measur…
38.1K views9 months ago
FacebookGilead Sciences
Gilead Sciences helped transform hepatitis C treatment and developed breakthrough treatments in HIV - and they’re just getting started. They’re committed to tackling today’s toughest health challenges, from HIV to cancer, while fueling local economies and creating cutting-edge research jobs. Their $32B investment in manufacturing and R&D facilities in the U.S. will power the next generation of treatments for patients while supporting local economies and skilled workers. Hear more from CEO Daniel
1:35
Gilead Sciences helped transform hepatitis C treatment and develop…
82 views3 months ago
FacebookPhRMA
Take a spin through the latest in Gilead’s science and innovation in our new series, The Centrifuge Sessions. Today we sit down with Barry Crittenden, Executive Director of Clinical Development, to discuss how Gilead is helping make an impact for people living with primary biliary cholangitis (PBC), a rare autoimmune disease that affects the liver. | Gilead Sciences
2:32
Take a spin through the latest in Gilead’s science and innovation i…
383 viewsFeb 13, 2025
FacebookGilead Sciences
Gilead is developing inhaled remdesivir
1:18
Gilead is developing inhaled remdesivir
Jun 2, 2020
YahooReuters Videos
Transformative medicines have the greatest impact when they reach the people who need them most. Here, Johanna Mercier, Chief Commercial Officer, shares how Gilead works to help remove barriers to care, improve health equity and increase access to life-changing therapies – all of which underscore our commitment to being a responsible company. #GileadForGood | Gilead Sciences
1:25
Transformative medicines have the greatest impact when they reach t…
348 viewsAug 19, 2024
FacebookGilead Sciences
2:21
At Gilead, we set and achieve bold ambitions in our fight against the …
31.1K viewsApr 10, 2025
FacebookGilead Sciences
1:05
At Gilead, patients are at the heart of everything we do – and we’re focu…
47.4K viewsSep 12, 2024
FacebookGilead Sciences
0:26
#PrimaryBiliaryCholangitis (PBC) is a rare, chronic autoimmune disea…
893K viewsJul 26, 2024
FacebookGilead Sciences
0:08
We’re digging in and building a future pipeline of medicine right h…
631 views6 months ago
FacebookGilead Sciences
0:47
“Every minute, every hour, every day that we work brings a medicin…
571 viewsOct 28, 2021
FacebookGilead Sciences
#mergersandacquisitions #pharmaceuticals #biotech #lifesc…
1 month ago
linkedin.com
0:43
For more than 35 years, Gilead has been at the forefront of tackling so…
74.5K views11 months ago
FacebookGilead Sciences
Gilead Sciences : Kite and Kiniksa Pharmaceuticals Announce Clinic…
Dec 12, 2019
marketscreener.com
4:32
Gilead CEO: Oral version of Covid drug Remdesivir in early testing
Jan 10, 2022
CNBCMeg Tirrell
0:56
At Gilead, we're focused on delivering transformative therapie…
89.9K views10 months ago
FacebookGilead Sciences
4:24
Gilead buys Kite for $11.9 billion
Aug 28, 2017
CNBCDavid Faber
2:30
Coronavirus patients reportedly responding to Gilead's experiment…
Apr 17, 2020
CNBC
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: W…
1 month ago
YahooJoel South
0:20
Gilead CEO Daniel O’Day breaks down the company's new twice-a-…
1.2K viewsJan 12, 2023
FacebookCNBC
27:20
Gilead CEO says company's moving quickly with FDA for approval of c…
May 1, 2020
CNBC
0:33
Merck awarded $2.54B in patent suit against Gilead
Dec 16, 2016
CNBC
1:47
Gilead says NIAID trial of remdesivir met its 'primary goal'
Apr 29, 2020
CNBCMeg Tirrell
0:11
As a practicing physician and long-time cancer researcher, Gilead’s S…
308 viewsJan 25, 2023
FacebookGilead Sciences
0:22
As part of Gilead and Kite, A Gilead Company's ongoing commitment t…
4.3K views4 months ago
FacebookGilead Sciences
ADVERTISEMENT by Gilead — Taking Steps Towards a Future Fr…
4 months ago
nytimes.com
0:51
Guided by our long-standing commitment to the region and the …
18.5K views1 month ago
FacebookGilead Sciences
1:40
Gilead Sciences - Gilead Company Overview & 2021 Drug Pipeline
3.7K viewsMay 3, 2021
YouTubeBioTech Health X
0:58
At Gilead, we’ve spent decades focusing on #HIV and pushing the …
77.8K views11 months ago
FacebookGilead Sciences
See more videos
Static thumbnail place holder